How a team of AIs discovered a promising lung-cancer drug

TL;DR - Researchers built a “virtual biotech” comprising up to 37,000 AI agents coordinated by a chief-scientist agent to identify a promising lung-cancer drug candidate. The brief description signals a large-scale agentic approach to drug discovery, but provides no details about the candidate or its validation.

• The system organizes thousands of specialized agents under a central coordinating agent.
• It applies a multi-agent workflow to biomedical research and drug discovery.
• “Promising” does not establish clinical effectiveness; the provided content reports no experimental or trial results.